
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | 2026-05-19 | SKARVAN KATHLEEN | Director | Sale | 40.0K | $35.48 | $1.42M | 35.6K | View ↗ | |
| 2025-09-11 | 2025-09-12 | Summers Andrew | Director | Sale | 3,153 | $24.42 | $77K | 0 | View ↗ | |
| 2025-09-10 | 2025-09-12 | Summers Andrew | Director | Sale | 62.6K | $24.32 | $1.52M | 3,153 | View ↗ |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net revenues | $64.0M+17.0% | $54.7M+13.8% | $48.1M+15.4% | $41.7M+16.5% | $35.8M |
| Cost of revenues | $14.0M+8.0% | $13.0M+12.5% | $11.5M+13.0% | $10.2M+20.9% | $8.5M |
| Gross profit | $50.0M+19.8% | $41.7M+14.3% | $36.5M+16.1% | $31.4M+15.2% | $27.3M |
| Selling, general and administrative | $39.3M+14.0% | $34.5M+9.2% | $31.6M+16.5% | $27.1M+20.8% | $22.4M |
| Research and development | $996K+51.8% | $656K-28.4% | $916K-32.4% | $1.4M-21.3% | $1.7M |
| Total operating expenses | $40.3M+14.7% | $35.1M+8.1% | $32.5M+14.2% | $28.5M+17.8% | $24.2M |
| Operating income | $9.7M+46.8% | $6.6M+64.2% | $4.0M+34.9% | $3.0M-5.4% | $3.1M |
| Interest income, net | $624K+37.1% | $455K+483.3% | $78K+212.0% | $25K-7.4% | $27K |
| Net income before income taxes | $10.3M+46.2% | $7.0M+72.2% | $4.1M+36.3% | $3.0M-5.4% | $3.2M |
| Income tax expense | $2.7M+45.7% | $1.9M+105.0% | $920K+32.9% | $692K-14.0% | $805K |
| Net income | $7.5M+46.3% | $5.2M+62.7% | $3.2M+37.4% | $2.3M-2.4% | $2.4M |
| Basic (in dollars per share) | $0.89+48.3% | $0.6+62.2% | $0.37+37.0% | $0.27-3.6% | $0.28 |
| Diluted (in dollars per share) | $0.85+46.6% | $0.58+61.1% | $0.36+38.5% | $0.26-3.7% | $0.27 |
| Basic (in shares) | $8.5M-1.3% | $8.6M+1.2% | $8.5M-0.1% | $8.5M-1.1% | $8.6M |
| Diluted (in shares) | $8.9M+0.6% | $8.9M+1.9% | $8.7M-0.8% | $8.8M-1.6% | $8.9M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Teladoc Health Broadens Virtual Care Reach Through Walmart Platform
Small-cap healthcare stocks ranked by quant ratings after earnings season
Zacks Industry Outlook Highlights Electromed, Globus Medical and Intuitive Surgical
3 Medical Instrument Stocks Exploring GenAI to Tackle Industry Woes